vs
镜泰（GNTX）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是镜泰的1.1倍（$622.0M vs $586.8M），Royalty Pharma plc净利率更高（34.4% vs 16.0%，领先18.5%），镜泰同比增速更快（562.1% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 1.2%）
镜泰（Gentex Corp）是美国电子科技企业，面向汽车行业研发生产自动防眩目后视镜、摄像头式驾驶辅助系统等产品，为各类航空市场供应可调光飞机舷窗，同时面向北美消防市场提供光电烟雾探测器、信号设备及HomeLink无线系列产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GNTX vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.1倍
$586.8M
营收增速更快
GNTX
高出557.3%
4.8%
净利率更高
RPRX
高出18.5%
16.0%
两年增速更快
RPRX
近两年复合增速
1.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $586.8M | $622.0M |
| 净利润 | $93.8M | $214.2M |
| 毛利率 | 34.0% | — |
| 营业利润率 | 20.1% | 62.4% |
| 净利率 | 16.0% | 34.4% |
| 营收同比 | 562.1% | 4.8% |
| 净利润同比 | -1.1% | 2.9% |
| 每股收益（稀释后） | $0.44 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GNTXRPRX
| Q1 26 | $586.8M | — | ||
| Q4 25 | $644.4M | $622.0M | ||
| Q3 25 | $655.2M | $609.3M | ||
| Q2 25 | $657.9M | $578.7M | ||
| Q1 25 | $576.8M | $568.2M | ||
| Q4 24 | $541.6M | $593.6M | ||
| Q3 24 | $608.5M | $564.7M | ||
| Q2 24 | $572.9M | $537.3M |
净利润GNTXRPRX
| Q1 26 | $93.8M | — | ||
| Q4 25 | $93.3M | $214.2M | ||
| Q3 25 | $101.0M | $288.2M | ||
| Q2 25 | $96.0M | $30.2M | ||
| Q1 25 | $94.9M | $238.3M | ||
| Q4 24 | $87.7M | $208.2M | ||
| Q3 24 | $122.5M | $544.0M | ||
| Q2 24 | $86.0M | $102.0M |
毛利率GNTXRPRX
| Q1 26 | 34.0% | — | ||
| Q4 25 | 34.8% | — | ||
| Q3 25 | 34.4% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 33.2% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 33.5% | — | ||
| Q2 24 | 32.9% | — |
营业利润率GNTXRPRX
| Q1 26 | 20.1% | — | ||
| Q4 25 | 18.6% | 62.4% | ||
| Q3 25 | 18.7% | 70.1% | ||
| Q2 25 | 18.0% | 36.3% | ||
| Q1 25 | 19.6% | 94.0% | ||
| Q4 24 | 16.6% | 60.9% | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 20.1% | 50.2% |
净利率GNTXRPRX
| Q1 26 | 16.0% | — | ||
| Q4 25 | 14.5% | 34.4% | ||
| Q3 25 | 15.4% | 47.3% | ||
| Q2 25 | 14.6% | 5.2% | ||
| Q1 25 | 16.4% | 41.9% | ||
| Q4 24 | 16.2% | 35.1% | ||
| Q3 24 | 20.1% | 96.3% | ||
| Q2 24 | 15.0% | 19.0% |
每股收益（稀释后）GNTXRPRX
| Q1 26 | $0.44 | — | ||
| Q4 25 | $0.43 | $0.49 | ||
| Q3 25 | $0.46 | $0.67 | ||
| Q2 25 | $0.43 | $0.07 | ||
| Q1 25 | $0.42 | $0.55 | ||
| Q4 24 | $0.39 | $0.46 | ||
| Q3 24 | $0.53 | $1.21 | ||
| Q2 24 | $0.37 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $175.0M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $3.0B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GNTXRPRX
| Q1 26 | $175.0M | — | ||
| Q4 25 | $151.0M | $618.7M | ||
| Q3 25 | $183.4M | $938.9M | ||
| Q2 25 | $141.1M | $631.9M | ||
| Q1 25 | $307.1M | $1.1B | ||
| Q4 24 | $255.6M | $929.0M | ||
| Q3 24 | $200.1M | $950.1M | ||
| Q2 24 | $275.8M | $1.8B |
总债务GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $9.7B | ||
| Q3 25 | $2.5B | $9.6B | ||
| Q2 25 | $2.4B | $9.5B | ||
| Q1 25 | $2.5B | $9.8B | ||
| Q4 24 | $2.5B | $10.3B | ||
| Q3 24 | $2.4B | $10.3B | ||
| Q2 24 | $2.4B | $9.8B |
总资产GNTXRPRX
| Q1 26 | $3.0B | — | ||
| Q4 25 | $2.9B | $19.6B | ||
| Q3 25 | $2.9B | $19.3B | ||
| Q2 25 | $2.8B | $18.3B | ||
| Q1 25 | $2.8B | $17.6B | ||
| Q4 24 | $2.8B | $18.2B | ||
| Q3 24 | $2.7B | $18.0B | ||
| Q2 24 | $2.7B | $17.7B |
负债/权益比GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $125.5M | $827.1M | ||
| Q3 25 | $147.0M | $702.6M | ||
| Q2 25 | $166.1M | $364.0M | ||
| Q1 25 | $148.5M | $596.1M | ||
| Q4 24 | $154.4M | $742.5M | ||
| Q3 24 | $84.7M | $703.6M | ||
| Q2 24 | $129.3M | $658.2M |
自由现金流GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | $99.8M | — | ||
| Q3 25 | $111.4M | — | ||
| Q2 25 | $135.0M | — | ||
| Q1 25 | $111.8M | — | ||
| Q4 24 | $112.7M | — | ||
| Q3 24 | $45.4M | — | ||
| Q2 24 | $97.5M | — |
自由现金流率GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 15.5% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | 19.4% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 7.5% | — | ||
| Q2 24 | 17.0% | — |
资本支出强度GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 5.5% | — |
现金转化率GNTXRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.35× | 3.86× | ||
| Q3 25 | 1.46× | 2.44× | ||
| Q2 25 | 1.73× | 12.06× | ||
| Q1 25 | 1.57× | 2.50× | ||
| Q4 24 | 1.76× | 3.57× | ||
| Q3 24 | 0.69× | 1.29× | ||
| Q2 24 | 1.50× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GNTX
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
